BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Bluejay Diagnostics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.05 (-6.46%)
Close on Oct 19, 2026
- Market cap
- $1.45M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$9.6236 (−93.25%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $1.45M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.15
- Dividend yield
- –
- Free cash flow yield
- -430.06%
Fundamentals
- Net income
- -$7.27M
- EPS, diluted
- -$15.25
- Free cash flow
- -$6.23M
- Book value per share
- $4.53
- Diluted shares
- 2M
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$7.37M
Net income
-$7.27M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months